← Leaderboards
Julie Eiseman
University Of Pittsburgh At Pittsburgh
$289,839
Attributed
$289,839
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $143.1K · FY2016–21$200K$150K$100K$50K$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$289,839 · 1
By mechanism
N02$289,839 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Candace S Johnson$18,922,226
- Michael A Pulsipher$13,522,310
- John Munn Kirkwood$15,450,309
- Jennifer R Grandis$109,711,044
- Jun Chen$22,616,112
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsPlasmaEvaluationSamplingDrug KineticsRouteTopoisomerase-I InhibitorSeriesClinicUrinePhase I TrialAnalogSiteDevelopmental Therapeutics ProgramDesignCancer PatientContractsContractorBiologicalAwardFormulationExerciseHigh Pressure Liquid ChromatographyBinding Proteins
Grant awards (4)
Title: Determination of LMP744 (NSC 706744) Levels in Human Plasma and Urine Samples from an NCI Phase I Trial.POP: 04/10/2017 - 04/09/2018$134,113
N02 · FY2021 · CA · contact PI
Title: "Testing formulations for small-molecule drug candidates suitable for early pharmacokinetic assessments."POP: 06/16/2017 - 06/15/2021$11,591
N02 · FY2018 · CA · contact PI
Title: Determination of LMP744 (NSC 706744) Levels in Human Plasma and Urine Samples from an NCI Phase I Trial.POP: 04/10/2017 - 04/09/2018$143,135
N02 · FY2017 · CA · contact PI
IGF::OT::IGF KICK-OFF MEETING PRECLINICAL PHARMACOKINETIC & PHARMACOLOGY EVALUATIONS OF AGENTS BEING DEVELOPED FOR CANCER PATIENTS, 7/1/2016-9/30/16, HHSN261201600022I$1,000
N02 · FY2016 · CA · contact PI